Many breast cancer patients who undergo chemotherapy are given Taxol (paclitaxel) as part of their regimen. Chemotherapy is designed to destroy any remaining cancer cells in the breast and the remainder of the body. Chemotherapy is effective in improving breast cancer survivorship: numerous studies have found that it protects against breast cancer recurrence and death.
One 2015 study reported that stress hormones reduced the efficacy of Taxol in triple negative (ER-/PR-/HER2-) breast cancer cells.
Taxol and other taxanes (e.g., Taxotere (docetaxel)) can result in side effects such as hair loss, mouth sores, nausea, fatigue, low white blood cell count, neuropathy, muscle and joint pain, cognitive impairment (chemo brain) and serious infections. While obtaining relief from these side effects obviously is desirable, it is very important for breast cancer patients to avoid consuming foods or taking supplements that will lessen the cytotoxic impact of chemotherapy on breast cancer cells.
Avoid most supplements during chemotherapy
Taking multivitamins during chemotherapy might help protect cancer cells from the toxic effects of the treatment and we do not recommend it. A variety of other micronutrients (curcumin, EGCG, gamma-linolenic acid (GLA), I3C, DIM, luteolin, and resveratrol) have been studied and found to increase the effectiveness of Taxol in laboratory experiments. The relevant studies are presented in our article on breast cancer diet during Taxol chemotherapy. However, safe and effective dosages for these supplements during chemotherapy have not been established. We suggest obtaining these compounds by consuming food rather than taking them in concentrated form. Taking them separately from the other micronutrients found in foods could have unintended adverse effects. For example, one study reported that resveratrol alone promoted mammary tumor growth and metastasis in a mouse model of estrogen receptor negative (ER-) breast cancer, whereas it inhibited it in combination with quercetin and catechin (all three polyphenols are found in grapes).
Milk thistle, a relative of artichoke, traditionally has been used for its liver-protective properties, but increasingly is being used by cancer patients. Milk thistle is the best known source of the compound flavonoid silymarin, which contains silybin. Silybin has been shown to inhibit growth and induce apoptosis in human breast cancer cells and HER-2/neu overexpressing (HER2+) mammary tumors in a mouse model. However, one study found that treatment of human breast cancer tumors in rodents with silymarin isolated from milk thistle stimulated cancer growth. Therefore, we caution breast cancer patients against taking concentrated milk thistle, artichoke or silymarin supplements.
Many women undergoing chemotherapy develop abnormally low iron levels. Since blood counts usually are monitored during chemotherapy, these women will be identified and treated. However, based on the available evidence, women on chemotherapy without low iron levels should avoid iron supplements (including those in multivitamins), as well as sources of heme iron (from non-plant sources) such as red meat, shellfish or any type of liver. The body absorbs heme iron more effectively than nonheme iron from plant sources such as spinach and dry beans. Tumeric contains curcumin, which has been shown to be an iron chelator, which may be helpful in reducing iron stores.
Pain killers and Taxol
While the prescription pain medication celecoxib (Celebrex) has been shown to be associated with reduced breast cancer risk, it should not be taken during chemotherapy. Celebrex has been shown to reduce the effectiveness of Adriamycin, 5-FU (5-fluorouracil ), and cisplatin. Aspirin also has the potential to interfere with chemotherapy. Use of ibuprofen (Advil, Motrin) has been found to be associated with increased risk of hormone receptor positive (ER+/PR+) breast cancer, although we are not aware of research specifically regarding any interactions with Taxol. Acetaminophen (Tylenol) appears to be the best choice while on Taxol.
Beta blockers and Taxol
There is some evidence that beta blocker use during chemotherapy could enhance its effectiveness, especially against triple negative breast cancer. Beta blockers are used to treat hypertension, abnormal heart rhythms, and heart failure. Of the beta blockers studied, propranolol (Inderal) appears to have the strongest synergistic effects when combined with Taxol.
Light at night and Taxol
Recent evidence suggests that sleeping while exposed to light, even dim light, could reduce the effectiveness of treatment with Taxol and promote resistance to chemotherapy.
Exercise during chemotherapy
Regular exercise has been shown to reduce fatigue in cancer patients undergoing chemotherapy. However, one study suggested that intense or prolonged physical activity a couple of days before the start of radiation or chemotherapy has significant potential to reduce the benefits of the treatments. Based on the available evidence, light to moderate aerobic exercise appears to be safe during treatment with Taxol and could reduce fatigue.
Please see our article on how to optimize your breast cancer diet for information on what to eat during all stages of treatment and recovery. Below are links to recent studies on Taxol and breast cancer. For a more complete list of studies, please click on the tag Taxol.